Celldex Therapeutics, Inc CLDX
$42.61
-5.04%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | FORM 8-K | 2026-08-06 | View → |
| 8-K | FORM 8-K | 2026-07-15 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 8-K | FORM 8-K | 2026-06-26 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | FORM 8-K | 2026-05-07 | View → |
| DEF 14A | FORM DEF 14A | 2026-04-29 | View → |
| 424B5 | 424B5 | 2026-04-02 | View → |
| 8-K | FORM 8-K | 2026-04-02 | View → |
| 424B5 | 424B5 | 2026-04-01 | View → |
| 10-K | 10-K | 2026-02-25 | View → |
| 8-K | FORM 8-K | 2026-02-25 | View → |
| 4 | Insider transaction | 2026-01-06 | View → |
| 4 | Insider transaction | 2025-12-17 | View → |
| 4 | Insider transaction | 2025-12-08 | View → |
| 4 | Insider transaction | 2025-11-17 | View → |
| 4 | Insider transaction | 2025-11-12 | View → |
| 10-Q | 10-Q | 2025-11-10 | View → |
| 8-K | FORM 8-K | 2025-11-10 | View → |
| 8-K | FORM 8-K | 2025-08-19 | View → |
| 4 | Insider transaction | 2025-08-15 | View → |
| 10-Q | 10-Q | 2025-08-07 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $42.61
- Market Cap
- $3.52 billion
- 52-Week Range
- $19.72 – $45.14
- Average Volume
- 965K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.